Multiple Myeloma Clinical Trials

A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 12 clinical trials
Assessment of Bortezomib (Alvocade ) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients

Bortezomib considered the standard of care for treating multiple myeloma patients, we aimed to assess the safety and efficacy of newly approved drug (Alvocade ) in Iraq, in newly diagnosed

  • 0 views
  • 25 Jan, 2021
  • 1 location
Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

To characterize safety associated with the use of Kyprolis under the locally approved label.

  • 0 views
  • 17 Jun, 2021
  • 18 locations
Prolonged Protection From Bone Disease in Multiple Myeloma

Multiple Myeloma compared to conventional radiography

  • 18 views
  • 26 Jan, 2021
  • 1 location
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma

Multiple myeloma (MM) is a common malignant hematology disease. The development of proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) significantly improved the survival of MM

lenalidomide
bortezomib
proteasome inhibitor
dexamethasone
multiple myeloma
  • 1 views
  • 23 Jan, 2021
  • 1 location
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal proliferation of monoclonal plasma cells in the bone marrow. The survival of MM patients varies from less than 6 months to

serum calcium
melphalan
hypercalcemia
bone marrow plasma cells
calcium
  • 4 views
  • 10 May, 2021
  • 1 location
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

This phase IV trial studies how well influenza vaccination works in preventing infections such as influenza in patients with plasma cell disorders. Influenza infections may theoretically support the growth of tumor cells and improving protection against influenza may improve the status of patients' plasma cell disorder. Giving influenza vaccination may …

  • 2 views
  • 13 May, 2021
  • 2 locations
A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

The purpose of this study is to demonstrate the safety profile of daratumumab in routine clinical practice when given as monotherapy in Indian participants with relapsed and refractory multiple

immunotherapeutic agent
daratumumab
proteasome inhibitor
refractory multiple myeloma
  • 110 views
  • 02 Jun, 2021
  • 20 locations
An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)

The purpose of this study is to determine the progression-free survival (PFS) at 2 years for MM participants previously receiving a bortezomib-based induction regimen to IRD.

lenalidomide
bortezomib
line of therapy
vasectomy
dexamethasone
  • 196 views
  • 13 Jun, 2021
  • 34 locations
Ixazomib Lenalidomide and Combination for Maintenance in NDMM Patients

diagnosed multiple myeloma in China.

lenalidomide
maintenance therapy
ixazomib
  • 1 views
  • 24 Jan, 2021
  • 1 location
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

considered an acceptable option for standard of care for patients with multiple myeloma receiving antiangiogenesis agents with chemotherapy and/or dexamethasone as well as for postoperative prophylaxis

aspirin
ovarian epithelial carcinoma
tumor debulking
interval debulking surgery
cancer
  • 0 views
  • 16 Jun, 2021
  • 1 location